Nexeon Medsystems (OTCMKTS:NXNN – Get Free Report) and Vivani Medical (NASDAQ:VANI – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.
Analyst Recommendations
This is a breakdown of current recommendations and price targets for Nexeon Medsystems and Vivani Medical, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Nexeon Medsystems | 0 | 0 | 0 | 0 | 0.00 |
Vivani Medical | 0 | 0 | 1 | 0 | 3.00 |
Vivani Medical has a consensus target price of $4.00, indicating a potential upside of 288.35%. Given Vivani Medical’s stronger consensus rating and higher probable upside, analysts plainly believe Vivani Medical is more favorable than Nexeon Medsystems.
Insider and Institutional Ownership
Volatility & Risk
Nexeon Medsystems has a beta of 6.98, indicating that its stock price is 598% more volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 2.76, indicating that its stock price is 176% more volatile than the S&P 500.
Valuation and Earnings
This table compares Nexeon Medsystems and Vivani Medical”s revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Nexeon Medsystems | N/A | N/A | N/A | N/A | N/A |
Vivani Medical | N/A | N/A | -$25.65 million | ($0.44) | -2.34 |
Profitability
This table compares Nexeon Medsystems and Vivani Medical’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Nexeon Medsystems | N/A | N/A | N/A |
Vivani Medical | N/A | -102.42% | -49.21% |
About Nexeon Medsystems
Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.
About Vivani Medical
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
Receive News & Ratings for Nexeon Medsystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nexeon Medsystems and related companies with MarketBeat.com's FREE daily email newsletter.